Caroline Humer
Caroline Humer
CRITIC
img-contested
N/A
0 reviews
PUBLIC
img-contested
N/A
0 reviews

RECENT ARTICLES

Sort by:
No Rating
U.S. pharmacies attract new flu shot customers as coronavirus surges

U.S. pharmacies attract new flu shot customers as coronavirus surges

This article was published more than 2 years agoCommentGift ShareWalmart, Walgreens Boots Alliance, CVS Health and Rite Aid report that demand for flu shots at their U.S. pharmacies is up sharply — in some cases double from last year — as people try to protect themselves from influenza in the midst of a worsening covid-19 pandemic.The pharmacies have told Reuters they are giving millions more flu shots than they have in past years, filling a gap from covid-19 for wary consumers who are avoiding the doctor’s office. The gains represent millions of dollars in potential profit.U.S. public...

November 16, 2020
Share
Save
Review
No Rating
Special Report: Big Pharma wages stealth war on drug price watchdog

Special Report: Big Pharma wages stealth war on drug price watchdog

By (Reuters) - As evidence grew this spring that the drug remdesivir was helping COVID-19 patients, some Wall Street investors bet on analysts’ estimates that its maker, Gilead Sciences Inc, could charge up to $10,000 for the treatment.Then a small but increasingly influential drug-pricing research organization, the Institute for Clinical and Economic Review (ICER), said the treatment only justified a price between $2,800 and $5,000. Shortly after, Gilead announced it would charge about $3,100 for a five-day treatment and $5,700 for ten days - in line with the ICER recommendation.The...

September 11, 2020
Share
Save
Review
No Rating
COVID-19 long-term toll signals billions in healthcare costs ahead

COVID-19 long-term toll signals billions in healthcare costs ahead

By , , NEW YORK (Reuters) - Late in March, Laura Gross, 72, was recovering from gall bladder surgery in her Fort Lee, New Jersey, home when she became sick again.Her throat, head and eyes hurt, her muscles and joints ached and she felt like she was in a fog. Her diagnosis was COVID-19. Four months later, these symptoms remain.Gross sees a primary care doctor and specialists including a cardiologist, pulmonologist, endocrinologist, neurologist, and gastroenterologist.“I’ve had a headache since April. I’ve never stopped running a low-grade temperature,” she said.Studies of COVID-19 patients...

August 3, 2020
Share
Save
Review
No Rating
CVS to offer companies COVID-19 testing program as U.S. cases rise

CVS to offer companies COVID-19 testing program as U.S. cases rise

By In addition to onsite and pharmacy testing, CVS also will offer symptom screenings, flu vaccines and other immunizations and add-on services like contact tracing for employees exposed to the virus.The unexpected surge in COVID-19 in states in the South and West has increased demand for testing workers on a regular basis, such as every two weeks or every month, said Troy Brennan, chief medical officer of the company, which operates pharmacies, a pharmacy benefit management (PBM) service and the Aetna insurance plan.“The general perception is that there is not going to be a sustained lull...

June 24, 2020
Share
Save
Review
No Rating
U.S. employers wary of coronavirus 'immunity' tests as they move to reopen

U.S. employers wary of coronavirus 'immunity' tests as they move to reopen

By , NEW YORK (Reuters) - U.S. employers have cooled to the idea of testing workers for possible immunity to the coronavirus as they prepare to reopen factories and other workplaces.Blood tests that check for antibodies to the new coronavirus have been touted by governments and some disease experts as a way to identify people who are less likely to fall ill or infect others. Italian automaker Ferrari NV has made antibody testing central to its “Back on Track” project to restarting factories.But many U.S. companies are not planning to use them, relying on face masks, temperature checks,...

May 15, 2020
Share
Save
Review
  • Total 6 items
  • 1
OUTLETS
reuters.com

reuters.com

CRITIC
img-trusted
100%
PUBLIC
img-trusted
80%
washingtonpost.com

washingtonpost.com

CRITIC
img-trusted
88%
PUBLIC
img-trusted
68%